Laserfiche WebLink
Breadcrumb Navigation:
UPDATE TO CAPITAL EXPENDITURES COMMITTEE REPORT TO STM 2022-3 <br /> CAPITAL EXPENDITURES COMMITTEE <br /> TOWN OF LEXINGTON <br /> UPDATE TO THE REPORT TO THE <br /> SPECIAL TOWN MEETING (STM) 2022-3 <br /> (Released October 24, 2022) <br /> Released November 1, 2022 <br /> Submitted by: <br /> Charles Lamb, Chair <br /> David G. Kanter, Vice-Chair& Clerk <br /> Sandy Beebee <br /> Michael Boudett <br /> Rodney Cole <br /> Lisah Rhodes <br /> This document provides an update to the Committee's Report with a dollar amount and source that <br /> were identified after the publishing of that Report,but prior to the STM. <br /> On Page 2: Replace the 3rd paragraph beginning "(h)" in its entirety with: <br /> (h) Capital, appropriate $2,375,392 to: Consisting of$1,675,999 from new levy growth per the Capital <br /> Stabilization Fund (CSF) Guideline; and $699,393, a one-time transfer, based on new levy growth under <br /> the Tax Increment Financing (TIF) agreement currently with Takeda Pharmaceuticals (properties at 200, <br /> 300, and 400 Shire Way). <br />